China (People’s Republic) approves AliquantumRx Inc.’s patent Salts and Polymorphs of Cethromycin for the Treatment of Bacterial and Protozoan Disease
AliquantumRx Inc., a Johns Hopkins FastForward company supported by Maryland Technology Development Corporation (TEDCO) is proud to announce the approval of its patent “Salts and Polymorphs of Cethromycin for the Treatment of Bacterial and Protozoan Disease” in People’s Republic of China. The Chinese patent number is patent number CN 115003309 B.